July 16, 2025 04:36 pm (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Rare oil painting of Mahatma Gandhi sells for an astounding Rs 1.7 crore | Brother of Yemeni man killed by Nimisha Priya opposes pardon of Kerala nurse | Can't win today's warfare with outdated weapons: CDS General Anil Chauhan seeks upgradation of India's defence system | Shubhanshu Shukla returns to Earth after his 18-day mission to space | India's Got Latent host Samay Raina, other influencers appear in SC over remarks mocking disabled | Drunk teenager who rammed Porsche into two-wheeler leaving two dead won't be tried as an adult | Jaishankar calls on China's President Xi Jinping in Beijing | Jaishankar calls on China's President Xi Jinping in Beijing | Supreme Court slams cartoonist Hemant Malviya for 'inflammatory' cartoon of PM Modi, RSS | Donald Trump threatens Russia with 'very severe tariffs' if no Ukraine negotiations within 50 days

Cabinet approves five year’s extension of Biomedical Research Career Programme

| @indiablooms | Mar 27, 2019, at 05:30 pm

New Delhi, Mar 27 (IBNS): The Union Cabinet, chaired by the Prime Minister Narendra Modi, has approved the continuation of the Biomedical Research Career Programme (BRCP), and Wellcome Trust (WT) /  DBT India Alliance beyond its initial 10-year term (2008-09 to 2018-29) to a new five year phase (2019-20 to 2023-24) with Department of Biotechnology (DBT) increasing its commitment to two times that of WT.

The total financial implication will be Rs. 1092 crore with DBT and WT contributing Rs.728 crore and Rs.364 crore respectively.

Over its 10 years of funding in a 1:1partnership, the Programme has fulfilled its objectives of building and nurturing talent of highest global standards in cutting-edge biomedical research in India, which has led to important scientific breakthroughs and applications to meet societal needs.

BRCP has made it attractive for high quality Indian scientists working abroad to return to India, and has increased the number of locations geographically within India where world-class biomedical research is undertaken.

In the extending phase, the Programme would continue to build this capacity as also strengthen clinical research and work towards addressing important health challenges for India.  Continuation of the Programme with increased stake from the Government of India is important to bring about these returns.

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.
Close menu